ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) have been given an average rating of “Moderate Buy” by the six research firms that are presently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The […]

Leave a Reply

Your email address will not be published.

Previous post Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives Consensus Rating of “Buy” from Analysts
Next post Coca-Cola FEMSA, S.A.B. de C.V. (NYSE:KOF) Receives $101.91 Average Price Target from Brokerages